Effects, cost, and cost-effectiveness of universal test and treat versus continued scale-up of ART at CD4 count ≤350 cells/µl in South Africa over the period 2012–2050 (Model D).
收藏Figshare2015-12-02 更新2026-04-29 收录
下载链接：
https://figshare.com/articles/dataset/_Effects_cost_and_cost_effectiveness_of_universal_test_and_treat_versus_continued_scale_up_of_ART_at_CD4_count_8804_350_cells_181_l_in_South_Africa_over_the_period_2012_8211_2050_Model_D_/829820
下载链接
链接失效反馈官方服务：
资源简介：
Costs and effects are discounted at an annual rate of 3%. Life-years concern the total life-years lived in South Africa of the entire population. Of these total life-years, 7% are life-years lived with HIV. Ranges reflect the variation in outcome due to the uncertainty in the parameter values that were quantified based on fitting the model to the data.
创建时间：
2015-12-02
